Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
ELVA vs BHST: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
ELVA Captures Overall Composite Edge (41.0 SELL vs 58.2 HOLD), While BHST Leads 4–2 on Growth & Valuation Pillars
ELVA Overall Winner
6-Pillar Tally: ELVA 2 – 4 BHST
Matrix Metrics: ELVA 6 – 4 BHST
As of Nov 20, 2026, Electrovaya Inc. Common Shares (ELVA) captures the overall head-to-head institutional edge over BioHarvest Sciences Inc. (BHST) on higher Unified Composite conviction (41.0/100 SELL vs. 58.2/100 HOLD) after splitting the core matrix 6–4 (led by Valuation Multiples, Profitability & Quality), while BHST wins 4–2 across the 6-pillar growth and valuation breakdown. ELVA trades at $3.27 (18.4x Forward P/E, 9.3% operating margin) versus BHST at $1.30 (N/M Forward P/E, -18.0% operating margin).
- Composite vs. Pillar Nuance: While BHST currently prints a higher short-term Unified Composite Score (58.2/100 HOLD vs. ELVA 41.0/100 SELL), ELVA captures the overall institutional head-to-head verdict (6–4 matrix metrics and 2–4 across the 6 pillars) due to superior fundamental profitability (9.3% vs. -18.0% operating margin) and revenue trajectory (+3.4% vs. +3.8% YoY).
- Technical & Structure Timing Caution: ELVA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 24.8); meanwhile BHST is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About ELVA vs BHST
ELVA
Head-to-Head Winner
Electrovaya Inc. Common Shares
$3.27
-11.86% 1D
Market Cap
$185.5M
TTM Revenue
$72M
Forward P/E
18.4x
Beta / 30D Vol
3.51β · 89% Vol
Unified Composite Score
41.0
SELL
Tech 25.0
Fund 48.0
Flow 66.0
Mom 59.0
Weinstein Technical Phase
Markdown · Sell / avoid
BHST
BioHarvest Sciences Inc. Common Stock
$1.30
-1.52% 1D
Market Cap
$29.9M
TTM Revenue
$35M
Forward P/E
N/M
Beta / 30D Vol
0.25β · 86% Vol
Unified Composite Score
58.2
HOLD
Tech 75.0
Fund 57.0
Flow 50.0
Mom 60.0
Weinstein Technical Phase
Markdown · Sell / avoid
6-Pillar Scorecard Institutional Category Breakdown (ELVA 2 – 4 BHST)
1. Valuation Multiples
ELVA
Forward P/E
18.4x
N/M
Trailing P/E
37.1x
N/M
PEG Ratio
0.28x
N/M
EV / Revenue
3.0x
0.7x
2. Growth & Scale
BHST
Revenue Growth (YoY)
+3.4%
+3.8%
Earnings Growth (YoY)
-69.3%
+0.0%
TTM Revenue (USD)
$72M
$35M
Market Cap
$185.5M
$29.9M
3. Profitability & Quality
ELVA
Gross Margin
33.0%
59.0%
Operating Margin
9.3%
-18.0%
Net Profit Margin
6.1%
-31.2%
Return on Equity (ROE)
9.8%
-142.5%
4. Balance Sheet & Cash Flow
BHST
Cash Generation (TTM)
-$37M
-$9.4M
Cash Flow Margin
-51.1%
-26.6%
Net Cash / Leverage
$28M Net Debt (0.61x D/E)
$5.1M Net Cash
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
BHST
Options Structure Phase
BREAKDOWN
UNCLASSIFIED
Current IV / %ile
88.1% (28th %ile)
N/A (N/A)
Put/Call OI Skew
0.91x (Balanced)
N/A
OBV Trend / Tech Phase
DISTRIBUTION · Markdown
NEUTRAL · Markdown
6. R&D & Supply-Chain Moat
BHST
OpEx & R&D Intensity
23.7% of Rev ($17M)
77.0% of Rev ($27M)
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Electrical Equipment & Parts Operator
Packaged Foods Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: ELVA (6) vs BHST (4)| Institutional Metric | ELVA | BHST | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $185.5M | $29.9M | ELVA | |
| Trailing P/E Ratio | 37.1x | N/M | ELVA | |
| Forward P/E Ratio | 18.4x | N/M | ELVA | |
| Revenue Growth (YoY) | +3.4% | +3.8% | BHST | |
| Operating Margin (TTM) | 9.3% | -18.0% | ELVA | |
| Net Profit Margin | 6.1% | -31.2% | ELVA | |
| Return on Equity (ROE) | 9.8% | -142.5% | ELVA | |
| 52-Week Range Position | 0% ($3–$13) | 6% ($1–$7) | BHST | |
| Beta / 30D Volatility | 3.51β · 89% Vol | 0.25β · 86% Vol | BHST | |
| Unified Institutional Score | 41.0 / 100 (SELL) | 58.2 / 100 (HOLD) | BHST | |
| Trailing 12M Revenue (USD) | $72M | $35M | Scale | |
| Gross Profit Margin (TTM) | 33.0% | 59.0% | Quality | |
| PEG Ratio & EV / Revenue | 0.28x PEG · 3.0x EV/Rev | N/M PEG · 0.7x EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | -$37M ($28M Net Debt (0.61x D/E)) | -$9.4M ($5.1M Net Cash) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
BHST +14.5 pp
3M Horizon
BHST +12.32 pp
6M Horizon
BHST +3.62 pp
1Y Horizon
ELVA +51.59 pp
Financial Trajectory Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)
| Period | ELVA Revenue | BHST Revenue | ELVA Op. Margin | BHST Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| Q2 '25 | $70M | $30M | 11.5% | -21.3% | ELVA |
| Q3 '25 | $80M | $40M | 11.7% | -10.1% | ELVA |
| Q4 '25 | $60M | $40M | 8.8% | -12.4% | ELVA |
| Q1 '26 | $70M | $30M | 12.1% | -21.6% | ELVA |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
ELVA
BREAKDOWN
Current IV
88.1%
IV Percentile
28th %ile
Put/Call OI Skew
0.91x (Balanced)
IV Regime
Balanced (25th–60th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
DISTRIBUTION
Exact ELVA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
BHST
UNCLASSIFIED
Current IV
N/A
IV Percentile
N/A
Put/Call OI Skew
N/A
IV Regime
Unclassified
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
Exact BHST Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
ELVA Moat Profile
Cyclical / Execution-Driven Positioning
Electrical Equipment & Parts Operator
OpEx & R&D Reinvestment
23.7% of Rev ($17M)
90D Engineering Disclosures
0 Published
BHST Moat Profile
Cyclical / Execution-Driven Positioning
Packaged Foods Operator
OpEx & R&D Reinvestment
77.0% of Rev ($27M)
90D Engineering Disclosures
0 Published
Investor FAQ ELVA vs BHST Key Questions & Quantitative Answers
As of Nov 20, 2026, Electrovaya Inc. Common Shares (ELVA) captures the overall head-to-head institutional edge over BioHarvest Sciences Inc. (BHST) on higher Unified Composite conviction (41.0/100 SELL vs. 58.2/100 HOLD) after splitting the core matrix 6–4 (led by Valuation Multiples, Profitability & Quality), while BHST wins 4–2 across the 6-pillar growth and valuation breakdown. ELVA trades at $3.27 (18.4x Forward P/E, 9.3% operating margin) versus BHST at $1.30 (N/M Forward P/E, -18.0% operating margin). Composite vs. Pillar Nuance: While BHST currently prints a higher short-term Unified Composite Score (58.2/100 HOLD vs. ELVA 41.0/100 SELL), ELVA captures the overall institutional head-to-head verdict (6–4 matrix metrics and 2–4 across the 6 pillars) due to superior fundamental profitability (9.3% vs. -18.0% operating margin) and revenue trajectory (+3.4% vs. +3.8% YoY). Technical & Structure Timing Caution: ELVA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 24.8); meanwhile BHST is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
BHST leads the Growth & Scale pillar: ELVA posts +3.4% YoY revenue growth and -69.3% YoY earnings growth on $72M TTM revenue (33.0% gross margin, 9.3% operating margin), compared with BHST at +3.8% YoY revenue growth and +0.0% YoY earnings growth on $35M TTM revenue (59.0% gross margin, -18.0% operating margin). Across the 4-period historical trajectory (Q2 '25 to Q1 '26), ELVA cumulative revenue shifted +0.0% while BHST shifted +0.0%. In operating R&D and SG&A reinvestment, ELVA deploys 23.7% of Rev ($17M) (0 90-day corporate R&D disclosures) versus 77.0% of Rev ($27M) (0 disclosures) for BHST.
ELVA screens cheaper on headline valuation multiples. ELVA trades at 18.4x Forward P/E, 37.1x Trailing P/E, 0.28x PEG, and 3.0x EV/Revenue (-51.1% FCF margin), whereas BHST trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.7x EV/Revenue (-26.6% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ELVA (9.8% ROE) versus BHST (-142.5% ROE) capital efficiency.
In options market volatility and institutional positioning, ELVA carries 88.1% implied volatility (28th %ile, Balanced (25th–60th %ile)), a 0.91x (Balanced) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (3.51β · 89% Vol realized risk). By comparison, BHST carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.25β · 86% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
BHST vs ELVA · Reverse Pair
ELVA vs PPIH
· Sector Peer
ELVA vs TOYO
· Sector Peer
BHST vs ACOG
· Sector Peer
BHST vs KGEI
· Sector Peer
BHST vs OBIO
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem